AdaptHealth Corp. Quarterly Goodwill in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
AdaptHealth Corp. quarterly Goodwill history and growth rate from Q4 2017 to Q2 2024.
  • AdaptHealth Corp. Goodwill for the quarter ending June 30, 2024 was $2.71B, a 23.7% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.71B -$840M -23.7% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.72B -$827M -23.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.72B -$820M -23.1% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $3.04B -$484M -13.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.55B +$36.7M +1.04% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.55B +$30.3M +0.86% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.55B +$32.7M +0.93% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $3.52B +$163M +4.84% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $3.52B +$284M +8.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.52B +$373M +11.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $3.51B +$2.51B +252% Dec 31, 2021 10-K 2024-02-27
Q3 2021 $3.36B +$2.55B +315% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $3.23B +$2.89B +842% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $3.14B +$2.8B +822% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $999M +$732M +274% Dec 31, 2020 10-K 2023-02-28
Q3 2020 $810M +$767M +1747% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $343M +$321M +1462% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $341M +$321M +1658% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $267M +$64.4M +31.8% Dec 31, 2019 10-K 2022-03-01
Q3 2019 $43.9M Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $22M Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $19.4M Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $202M +$164M +424% Dec 31, 2018 10-K 2020-03-06
Q4 2017 $38.6M Dec 31, 2017 10-K 2020-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.